Development of a nanobody-based, slide-free approach for 3D-Histological analysis of the spatial tumor microenvironment using lightsheet imaging
This project aims to revolutionize cancer histology through a nanobody-based 3D-histopathology approach, enabling rapid, spatially accurate analysis of tumor microenvironments for improved diagnosis and patient stratification.
Projectdetails
Introduction
For histopathological analysis and subsequent diagnosis of diseased tissues, a rapid and accurate histopathological and genetic analysis of biopsied tissues is essential. However, traditional 2-dimensional slide-based histopathological analysis does not represent spatial tissue structures and molecular targets sufficiently, which aggravates an accurate and spatial analysis of tissue, a detailed description of the tumor microenvironment, as well as patient stratification.
Proposed Solution
To overcome these limitations, I propose an innovative, nanobody-based 3D-histopathology approach using non-destructive volumetric lightsheet microscopy. This approach bears the potential to revolutionize the way pathological analysis of tumor samples is done.
Advantages of 3D-Histopathology
In comparison to conventional 2D-pathology, non-destructive 3D-histopathology allows:
- Rapid slide-free histological imaging of an entire tissue sample.
- Volumetric analysis of diagnostic relevant structures such as immune cells and vessels.
- Improved spatial analysis of cell distribution relevant to studying the microenvironment.
Methodology
To achieve this, we will generate nanobodies for improved wholemount tissue staining of the immune system as well as tumor-relevant markers.
Labeling Technique
By labelling nanobodies with cleavable fluorescent dyes using click chemistry and integration of linkers for stoichiometric and directed labeling, we will be able to perform several rounds of multiplex staining of the identical sample. This will provide cutting-edge diagnostic phenotyping of the specimen.
Downstream Applications
Due to the non-destructive nature of the optical-sectioning methodology, the sample will be available for downstream applications such as molecular diagnostics of the previously imaged specimen.
Conclusion
In summary, this innovative project holds great potential to revolutionize cancer histology by providing a spatial and detailed description of the tumor microenvironment, improving the diagnosis of tumor samples, and consequently enhancing patient stratification and outcome.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 30-6-2026 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- CHARITE - UNIVERSITAETSMEDIZIN BERLINpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Nanoscale Isotropic 3D Resolution using Omni-view Structured Light Sheet MicroscopyThis project aims to revolutionize biological imaging by developing a novel optical architecture for super-resolution microscopy that enhances 3D imaging resolution and sample longevity without trade-offs. | ERC Advanced... | € 2.293.558 | 2022 | Details |
Advanced X-ray Energy-sensitive Microscopy for Virtual HistologyThis project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Super-resolution microscopy for immune checkpoint inhibitors diagnosticsNANODIAGNOSTIC aims to translate super-resolution microscopy techniques into clinical tools for cancer diagnostics, enhancing patient stratification for effective immunotherapy. | ERC Proof of... | € 150.000 | 2022 | Details |
Lensless label-free nanoscopyThis project aims to develop deep UV lensless holotomographic nanoscopy for high-resolution, large-field imaging of live cells to enhance understanding of extracellular vesicles as disease biomarkers. | ERC Starting... | € 1.500.000 | 2024 | Details |
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC Advanced... | € 2.500.000 | 2025 | Details |
Nanoscale Isotropic 3D Resolution using Omni-view Structured Light Sheet Microscopy
This project aims to revolutionize biological imaging by developing a novel optical architecture for super-resolution microscopy that enhances 3D imaging resolution and sample longevity without trade-offs.
Advanced X-ray Energy-sensitive Microscopy for Virtual Histology
This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.
Super-resolution microscopy for immune checkpoint inhibitors diagnostics
NANODIAGNOSTIC aims to translate super-resolution microscopy techniques into clinical tools for cancer diagnostics, enhancing patient stratification for effective immunotherapy.
Lensless label-free nanoscopy
This project aims to develop deep UV lensless holotomographic nanoscopy for high-resolution, large-field imaging of live cells to enhance understanding of extracellular vesicles as disease biomarkers.
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Enabling the transition to 3D digital pathology3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally. | EIC Transition | € 2.493.683 | 2025 | Details |
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platformThe NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology. | EIC Transition | € 2.489.162 | 2023 | Details |
Chemometric histopathology via coherent Raman imaging for precision medicineThe CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification. | EIC Transition | € 2.441.979 | 2022 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGYOPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability. | EIC Pathfinder | € 3.276.577 | 2025 | Details |
Enabling the transition to 3D digital pathology
3DPATH aims to develop a clinically viable 3D tissue scanner using advanced light-sheet fluorescence microscopy to enhance histopathology accuracy and improve patient care globally.
Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platform
The NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology.
Chemometric histopathology via coherent Raman imaging for precision medicine
The CHARM project aims to revolutionize cancer diagnosis with a novel AI-integrated, label-free tissue analysis system, achieving high accuracy in tumor identification and classification.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
ADAPTIVE OPTICAL METASURFACES FOR REAL-TIME, LABEL-FREE AND NON-DESTRUCTIVE 7D DIGITAL PATHOLOGY
OPTIPATH aims to revolutionize tissue diagnosis by providing real-time, non-destructive 3D imaging using advanced optical technologies and machine learning to enhance accuracy and reduce variability.